DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...
Why Do Large B-Cell Lymphoma Patients With High Tumor Mutation Burden Relapse on CAR T-Cell Therapy?
Researchers explored this question at ASH and shared data suggesting genomic instability in tumors with high TMB likely ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback